Cargando...
Current status of the adjuvant therapy in uterine sarcoma: A literature review
Uterine sarcomas (US) are rare mesenchymal tumours accounting approximately for 3%–7% of all uterine cancers. Histologically, US are classified into mesenchymal tumours or mixed epithelial and mesenchymal tumours. The group of mesenchymal tumours includes uterine leiomyosarcoma (uLMS, 65% of cases),...
Guardado en:
| Publicado en: | World J Clin Cases |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6692269/ https://ncbi.nlm.nih.gov/pubmed/31417921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i14.1753 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|